1. What is the starting dose and incremental increase in MTCD escalation?
2. As per IndexInvestor what number of patients are required in Australia v. overseas populations for 1A / 1B?
3. Will cancer types impact on the number of patients required under the Bayesian design?
4. Whilst timeframes are fluid are you expecting readouts of 1B prior to May 2026 opt deadline?
5. Hypothetically, If a paper has been submitted for a scientific review but not published, could it be updated to mention a specific clinical trial that has commenced?
Most importantly, How excited is the Race team for the next 12 months?
RAC Price at posting:
$1.25 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)